On September 20, Vanguard Group made significant investments in the Indian stock market, purchasing shares worth approximately Rs 1000 crore across seven listed companies through bulk deals. Simultaneously, UBS Principal Capital Asia Limited reduced its holdings in various companies on the same day.
Key Transactions:
Vanguard Group Inc A/C Vanguard Total International Stock Index Fund:
- Arvind Fashions: Acquired 6.72 lakh shares at an average price of Rs 588.68.
- Concord Biotech: Bought 6.98 lakh shares at Rs 2596.08.
- Five-Star Business Finance: Purchased 20.56 lakh shares at Rs 806.46.
- Genus Power Infratech: Acquired 15.2 lakh shares at Rs 416.31.
- Marksans Pharma: Bought 26.97 lakh shares at Rs 316.85.
- Sansera Engineering: Acquired 13.2 lakh shares at Rs 1669.38.
- VA Tech Wabag: Bought 3.13 lakh shares at Rs 1516.23.
Vanguard Emerging Markets Stock Index Fund A Series of Vanguard International:
- Concord Biotech: Acquired 5.77 lakh shares at Rs 2596.08.
- Five-Star Business Finance: Purchased 17.23 lakh shares at Rs 806.46.
- Marksans Pharma: Bought 20.13 lakh shares at Rs 316.85.
UBS Principal Capital Asia Limited Sell-Offs:
- Concord Biotech: Sold 7.4 lakh shares at an average price of Rs 2589.86.
- Five-Star Business Finance: Sold 15.8 lakh shares at Rs 806.46.
- IIFL Securities: Divested 17.11 lakh shares at Rs 309.84.
- Marksans Pharma: Sold 34.02 lakh shares at Rs 317.22.
These large-scale transactions highlight Vanguard’s continued confidence in the Indian market while UBS Principal Capital Asia Limited’s sell-offs reflect a shift in their portfolio strategy.
Do you have a news tip for Lakshmishree reporters? Please email us at media@lakshmishree.com
Source: Moneycontrol
News Desk
